132 related articles for article (PubMed ID: 3467650)
1. Antimicrobial activity of U-70138F (paldimycin), roxithromycin (RU 965), and ofloxacin (ORF 18489) against Chlamydia trachomatis in cell culture.
Stamm WE; Suchland R
Antimicrob Agents Chemother; 1986 Nov; 30(5):806-7. PubMed ID: 3467650
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal activity of ofloxacin versus roxithromycin in the treatment of Streptococcus pneumoniae.
Shah PM; Schäfer V; Hubener T; Metz C; Stille W
Drugs; 1987; 34 Suppl 1():9-13. PubMed ID: 3481332
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence.
Bailey JM; Heppleston C; Richmond SJ
Antimicrob Agents Chemother; 1984 Jul; 26(1):13-6. PubMed ID: 6383207
[TBL] [Abstract][Full Text] [Related]
4. Activity of ofloxacin against Chlamydia trachomatis.
Møller BR; Evans R; Kaspersen P; From E
Drugs; 1987; 34 Suppl 1():181-3. PubMed ID: 3481321
[No Abstract] [Full Text] [Related]
5. In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis.
Bowie WR; Shaw CE; Chan DG; Black WA
Antimicrob Agents Chemother; 1987 Mar; 31(3):470-2. PubMed ID: 2953304
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of gram-positive cocci to paldimycin.
Pohlod DJ; Saravolatz LD; Somerville MM
Antimicrob Agents Chemother; 1987 Jan; 31(1):104-7. PubMed ID: 3105438
[TBL] [Abstract][Full Text] [Related]
7. [Activity of a new quinoline derivative against Chlamydia trachomatis].
Mitsui Y; Higashitsutsumi M
Nippon Ganka Gakkai Zasshi; 1986 Aug; 90(8):1074-80. PubMed ID: 3464167
[No Abstract] [Full Text] [Related]
8. Antichlamydial activity of ofloxacin.
Hirai K; Une T
Microbiol Immunol; 1986; 30(5):445-50. PubMed ID: 3462450
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity of RU 28965 against Chlamydia trachomatis.
Cevenini R; Sambri V; La Placa M
Eur J Clin Microbiol; 1986 Oct; 5(5):598-600. PubMed ID: 3536506
[No Abstract] [Full Text] [Related]
10. [In vitro, activity of a new macrolide (RU 28965) against Chlamydia trachomatis and Ureaplasma urealyticum].
Sambri V; Rumpianesi F; Franchi L; Cevenini R
G Ital Chemioter; 1985; 32(1):175-6. PubMed ID: 3830774
[No Abstract] [Full Text] [Related]
11. In vitro activity of ciprofloxacin against clinical isolates of Chlamydia trachomatis.
Meier-Ewert H; Weil G; Millott G
Eur J Clin Microbiol; 1984 Aug; 3(4):372. PubMed ID: 6593220
[No Abstract] [Full Text] [Related]
12. In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.
Liebowitz LD; Saunders J; Fehler G; Ballard RC; Koornhof HJ
Antimicrob Agents Chemother; 1986 Dec; 30(6):948-50. PubMed ID: 3101590
[TBL] [Abstract][Full Text] [Related]
13. [Comparative in vitro activity of a new macrolide RU 28965 and of erythromycin against Chlamydia trachomatis].
Dutilh B; de Barbeyrac B; Lafferrière C; Bébéar C
Pathol Biol (Paris); 1986 May; 34(5):445-7. PubMed ID: 3534718
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of paldimycin (U-70138F) against gram-positive bacteria isolated from patients with cancer.
Rolston KV; LeBlanc B; Ho DH; Bodey GP
Antimicrob Agents Chemother; 1987 Apr; 31(4):650-2. PubMed ID: 3606069
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines.
Samra Z; Rosenberg S; Soffer Y; Dan M
Diagn Microbiol Infect Dis; 2001 Mar; 39(3):177-9. PubMed ID: 11337185
[TBL] [Abstract][Full Text] [Related]
16. [Susceptibility study on urogenital Chlamydia trachomatis to 19 kinds of antibiotics].
Bai H; Dong J; Ning B
Zhonghua Yi Xue Za Zhi; 1995 Jan; 75(1):11-4, 60. PubMed ID: 7600311
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of in vitro activity of ofloxacin against 73 strains of Chlamydia trachomatis isolated from gynecologic infections].
Catalan F; Milovanovic A; Prouteau C; Soulignac M
Pathol Biol (Paris); 1998 Feb; 46(2):144-6. PubMed ID: 9769927
[TBL] [Abstract][Full Text] [Related]
18. Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure.
Zheng H; Xue Y; Bai S; Qin X; Lu P; Yang B
Sex Transm Dis; 2015 Mar; 42(3):115-9. PubMed ID: 25668641
[TBL] [Abstract][Full Text] [Related]
19. The activity of miokamycin (MOM) against Chlamydia trachomatis and mycoplasmas in vitro.
Ridgway GL; Mumtaz G; Gabriel G; Oriel JD
J Antimicrob Chemother; 1983 Nov; 12(5):511-4. PubMed ID: 6608516
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis.
Lefèvre JC; Escaffre MC; Courdil M; Lareng MB
Pathol Biol (Paris); 1993 Apr; 41(4):313-5. PubMed ID: 8233628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
